TP53 and glioblastoma: They were also classified based on TP53 mutant and non-mutant tissue samples from the TCGA datasets (TCGA pan-cancer atlas with 592 samples of GBM) and shortlisted the ones that were in line with the previous comparisons, as shown in Table 3.